It is also used for the treatment of optic neuropathies, such as tobacco amblyopia and Leber's optic atrophy
Because it is a small molecule, it is studied orally/sublingually in the literature
A 10 mg vial covers 2-5 weekly doses depending on step
Initial Loading Phase Protocol In this first step, patients get B12 shots every day for one to two weeks
BPC-157 is investigated in preclinical research for its effects on tissue regeneration, angiogenesis, fibroblast migration, and cellular signaling across tendon, ligament, muscle, gastrointestinal, and vascular models
GHK-Cu is not on the FDAs restricted peptide lists